At the end of the latest market close, Immutep Limited (IMMP) was valued at $3.18. In that particular session, Stock kicked-off at the price of $3.12 while reaching the peak value of $3.30 and lowest value recorded on the day was $3.10. The stock current value is $3.38.
Recently in News on April 8, 2021, Immutep Achieves Fast Track Designation From US FDA For Efti, A Soluble Lag-3 Protein, In First Line Recurrent/Metastatic Head & Neck Cancer. Fast Track designation opens the potential for expedited development and review with the US FDA. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Immutep Limited had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $4.16 on 03/25/21, with the lowest value was $2.20 for the same time period, recorded on 03/05/21.
Immutep Limited (IMMP) full year performance was 340.99%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Immutep Limited shares are logging -57.55% during the 52-week period from high price, and 396.32% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.68 and $7.95.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 9861833 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Immutep Limited (IMMP) recorded performance in the market was 1.27%, having the revenues showcasing 1.92% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 206.29M.
The Analysts eye on Immutep Limited (IMMP)
During the last month, 0 analysts gave the Immutep Limited a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.89, with a change in the price was noted +1.24. In a similar fashion, Immutep Limited posted a movement of +58.54% for the period of last 100 days, recording 5,383,112 in trading volumes.
Technical rundown of Immutep Limited (IMMP)
Raw Stochastic average of Immutep Limited in the period of last 50 days is set at 59.23%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 49.43%. In the last 20 days, the company’s Stochastic %K was 39.85% and its Stochastic %D was recorded 39.56%.
Considering, the past performance of Immutep Limited, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 1.27%. Additionally, trading for the stock in the period of the last six months notably improved by 88.17%, alongside a boost of 340.99% for the period of the last 12 months. The shares increased approximately by 10.42% in the 7-day charts and went down by 29.27% in the period of the last 30 days. Common stock shares were driven by 1.92% during last recorded quarter.